For researchers

Each year more than a hundred researchers or research teams receive Cancer Foundation funding

Each year more than a hundred researchers or research teams receive Cancer Foundation funding to investigate new solutions for cancer diagnosis, prevention and treatment.

The Cancer Foundation is the leading private funder of cancer research in Finland.

The Cancer Foundation provides over €8-million annually in public donations for cancer research. The Cancer Foundation is the leading private funder of cancer research in Finland.

We support research directly by disbursing grants to researchers and research teams, as well as by funding the Finnish Cancer Registry and joint Nordic research projects.

 

 

Cancer Foundation’s major grants

This year, the Cancer Foundation awarded grants of €6,5 million for cancer research.

CANCER FOUNDATION FINLAND’S GRANTS

How and with what criteria does the Cancer Foundation award research grants? Grants for research and scientific activity are awarded annually in spring (travel grants) and autumn (research grants and dissertation grants). The grant decisions are made by the Board of the Cancer Foundation.

Instructions for grant recipients

General instructions for grant recipients

CANCER FOUNDATION FINLAND’S GRANTS

RESEARCH and DISSERTATION GRANTS

The Cancer Foundation supports clinical, epidemiological and psychosocial cancer research in Finland as well as basic cancer research.

Travel grants

The Cancer Foundation awards travel grants to cancer professionals for travel related to meetings and training. The grants are awarded based on the applicant’s merits as well as the cancer relevance of the meeting and its significance for developing the applicant’s professional skills.

OTHER SUPPORT FOR RESEARCH

In addition to research grants, the Cancer Foundation also supports research in other ways.

For instance, the Cancer Foundation supports research at the Finnish Cancer Registry with some 1.2 million euros annually.

Together with the K. Albin Johansson Foundation, the Cancer Foundation provides funding for research posts of the Foundation for the Finnish Cancer Institute, such as research professorships, senior scientist posts and postdoctoral researcher posts. Every two years, the Foundation for the Finnish Cancer Institute organises, together with a university, an international symposium for cancer research. The Cancer Foundation also supports the organisation of the symposium.

Furthermore, the Cancer Foundation co-funds joint Nordic research projects financed by the Nordic Cancer Union’s (NCU) Cancer Research Fund. Finland will chair the NCU in 2021–2023, and the Secretary General of the Cancer Society of Finland will chair the NCU Board. The Cancer Society is also responsible for the activities of the NCU Scientific Committee and for other secretariat services.

The Cancer Foundation can also, at its discretion, support scientific meetings or other scientific activities related to cancer prevention organised in Finland based on individual initiatives or proposals.

Professorship in cancer epidemiology

Together with Tampere University, the Cancer Foundation funds a part-time (20%) professorship in cancer epidemiology at the Unit of Health Sciences, Faculty of Social Sciences of Tampere University. The professor teaches courses and supervises doctoral dissertations in the International Doctoral Programme in Epidemiology and Public Health (IPPE). Currently, the professorship is held by Adjunct Professor (Title of Docent) Janne Pitkäniemi, Director of Statistics at the Finnish Cancer Registry. The Cancer Foundation has also supported Tampere University by covering the accommodation and living expenses of cancer epidemiologists from developing countries participating in the doctoral programme.

Online service for costs of cancer treatment

The Cancer Foundation maintains (in Finnish) an online service that provides updated information on the total costs of cancer by cancer type and region. The costs can also be examined by cost category. The service allows you to monitor cost development and compare cost levels and cost structures between regions. You can also follow the development of costs in relation to the number of new cancer cases.